VALUE OF THE DETECTION OF NEUROENDOCRINE DIFFERENTIATION IN PROSTATE CANCER

Background. Many investigators point out the importance of detecting the neuroendocrine differentiation of prostate adenocarcinoma (PA) and consider its relationship to the clinical picture of the disease and total Gleason scores (Gleason index).Objective: to study relations between the presence of...

Full description

Bibliographic Details
Main Authors: M. V. Kovylina, E. A. Prilepskaya, I. P. Sergeiko, T. N. Moiseenko, K. B. Kolantarev, A. V. Govorov, D. Yu. Pushkar
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Onkourologiâ
Subjects:
Online Access:https://oncourology.abvpress.ru/oncur/article/view/142
id doaj-8db5e0e8709144719eed277b27744442
record_format Article
spelling doaj-8db5e0e8709144719eed277b277444422021-07-29T08:41:37ZrusABV-pressOnkourologiâ 1726-97761996-18122014-07-0194434610.17650/1726-9776-2013-9-4-43-46157VALUE OF THE DETECTION OF NEUROENDOCRINE DIFFERENTIATION IN PROSTATE CANCERM. V. Kovylina0E. A. Prilepskaya1I. P. Sergeiko2T. N. Moiseenko3K. B. Kolantarev4A. V. Govorov5D. Yu. Pushkar6A. I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the Russian Federation, MoscowA. I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the Russian Federation, MoscowA. I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the Russian Federation, MoscowA. I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the Russian Federation, MoscowA. I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the Russian Federation, MoscowA. I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the Russian Federation, MoscowA. I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the Russian Federation, MoscowBackground. Many investigators point out the importance of detecting the neuroendocrine differentiation of prostate adenocarcinoma (PA) and consider its relationship to the clinical picture of the disease and total Gleason scores (Gleason index).Objective: to study relations between the presence of markers indicative of neuroendocrine differentiation in PA tissue, Gleason index, and disease characteristics.Materials and methods. The fragments of the postoperative histological specimens obtained from 30 patients after radical prostatectomy in 2008 were stained by an immunohistochemical assay to identify specific markers of neuroendocrine differentiation: chromogranin A (CgA) and synaptophysin. The expression of the markers of neuroendocrine differentiation was compared to the clinical stage of the disease and Gleason index that was used to allocate the patients to 3 groups: low-, moderate-, and high-grade tumors.Results. The patients» mean age was 67 ± 9.2 years. Groups 1, 2, and 3 included 5, 19, and 6 patients, respectively. The expression of CgA was found in 10 % of Group 1 patients, in 33 % in Group 2, and in 40% in Group 3. CgA expression considerably increased with a higher Gleason score (p = 0.024).Conclusion. The expression of CgA is more than that of other used markers and correlates with the clinically determined stage of the disease. The expression of CgA increases with a higher grade, which can be potentially used to predict the course of the disease. The limitations of this investigation are associated with its retrospective pattern and a small sample size. The findings need to be clarified in a large cohort study.https://oncourology.abvpress.ru/oncur/article/view/142prostate cancerradical prostatectomyneuroendocrine differentiationimmunohistochemical studiesgleason indexchromogranin asynaptophysin
collection DOAJ
language Russian
format Article
sources DOAJ
author M. V. Kovylina
E. A. Prilepskaya
I. P. Sergeiko
T. N. Moiseenko
K. B. Kolantarev
A. V. Govorov
D. Yu. Pushkar
spellingShingle M. V. Kovylina
E. A. Prilepskaya
I. P. Sergeiko
T. N. Moiseenko
K. B. Kolantarev
A. V. Govorov
D. Yu. Pushkar
VALUE OF THE DETECTION OF NEUROENDOCRINE DIFFERENTIATION IN PROSTATE CANCER
Onkourologiâ
prostate cancer
radical prostatectomy
neuroendocrine differentiation
immunohistochemical studies
gleason index
chromogranin a
synaptophysin
author_facet M. V. Kovylina
E. A. Prilepskaya
I. P. Sergeiko
T. N. Moiseenko
K. B. Kolantarev
A. V. Govorov
D. Yu. Pushkar
author_sort M. V. Kovylina
title VALUE OF THE DETECTION OF NEUROENDOCRINE DIFFERENTIATION IN PROSTATE CANCER
title_short VALUE OF THE DETECTION OF NEUROENDOCRINE DIFFERENTIATION IN PROSTATE CANCER
title_full VALUE OF THE DETECTION OF NEUROENDOCRINE DIFFERENTIATION IN PROSTATE CANCER
title_fullStr VALUE OF THE DETECTION OF NEUROENDOCRINE DIFFERENTIATION IN PROSTATE CANCER
title_full_unstemmed VALUE OF THE DETECTION OF NEUROENDOCRINE DIFFERENTIATION IN PROSTATE CANCER
title_sort value of the detection of neuroendocrine differentiation in prostate cancer
publisher ABV-press
series Onkourologiâ
issn 1726-9776
1996-1812
publishDate 2014-07-01
description Background. Many investigators point out the importance of detecting the neuroendocrine differentiation of prostate adenocarcinoma (PA) and consider its relationship to the clinical picture of the disease and total Gleason scores (Gleason index).Objective: to study relations between the presence of markers indicative of neuroendocrine differentiation in PA tissue, Gleason index, and disease characteristics.Materials and methods. The fragments of the postoperative histological specimens obtained from 30 patients after radical prostatectomy in 2008 were stained by an immunohistochemical assay to identify specific markers of neuroendocrine differentiation: chromogranin A (CgA) and synaptophysin. The expression of the markers of neuroendocrine differentiation was compared to the clinical stage of the disease and Gleason index that was used to allocate the patients to 3 groups: low-, moderate-, and high-grade tumors.Results. The patients» mean age was 67 ± 9.2 years. Groups 1, 2, and 3 included 5, 19, and 6 patients, respectively. The expression of CgA was found in 10 % of Group 1 patients, in 33 % in Group 2, and in 40% in Group 3. CgA expression considerably increased with a higher Gleason score (p = 0.024).Conclusion. The expression of CgA is more than that of other used markers and correlates with the clinically determined stage of the disease. The expression of CgA increases with a higher grade, which can be potentially used to predict the course of the disease. The limitations of this investigation are associated with its retrospective pattern and a small sample size. The findings need to be clarified in a large cohort study.
topic prostate cancer
radical prostatectomy
neuroendocrine differentiation
immunohistochemical studies
gleason index
chromogranin a
synaptophysin
url https://oncourology.abvpress.ru/oncur/article/view/142
work_keys_str_mv AT mvkovylina valueofthedetectionofneuroendocrinedifferentiationinprostatecancer
AT eaprilepskaya valueofthedetectionofneuroendocrinedifferentiationinprostatecancer
AT ipsergeiko valueofthedetectionofneuroendocrinedifferentiationinprostatecancer
AT tnmoiseenko valueofthedetectionofneuroendocrinedifferentiationinprostatecancer
AT kbkolantarev valueofthedetectionofneuroendocrinedifferentiationinprostatecancer
AT avgovorov valueofthedetectionofneuroendocrinedifferentiationinprostatecancer
AT dyupushkar valueofthedetectionofneuroendocrinedifferentiationinprostatecancer
_version_ 1721252700171010048